Publication year: 2011 Source: Journal of Cardiac Failure, Available online 9 September 2011 James E. Udelson, Martin Bilsker, Paul J. Hauptman, Rafael Sequeira, Ignatius Thomas, … BackgroundIncreased vasopressin levels may be present in patient with chronic heart failure (HF) and contribute to pathophysiology through effects on the vasopressin V2 receptor
Continue reading here:
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and…